文献速递新发突发、热带与寄生虫病

纯化寨卡病毒RNA依赖RNA聚合酶并用于筛选小分子抑制剂

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

本研究纯化了重组寨卡病毒NS5聚合酶,建立RdRp体外 assay,用于筛选寨卡病毒抑制剂。结果显示sofosbuvir三磷酸和DMB213均可抑制ZIKV RdRp活性,IC50分别为7.3和5.2 μM;细胞水平EC50分别为8.3和4.6 μM。S604T突变导致对sofosbuvir三磷酸耐药但不影响DMB213。

要点

  • 重组ZIKV NS5 RdRp可用于体外筛选核苷类和非核苷类抑制剂。
  • Sofosbuvir三磷酸和DMB213在酶水平和细胞水平均抑制ZIKV。
  • S604T突变介导对sofosbuvir三磷酸耐药,但不影响DMB213。

核心结论

  • 重组ZIKV RdRp assay可用于筛选核苷类化合物和干扰ZIKV复制的非核苷金属离子螯合剂。

研究设计与样本

  • 使用纯化的重组ZIKV NS5聚合酶建立RdRp体外 assay,并进行细胞水平验证。

主要发现

  • Sofosbuvir三磷酸和DMB213抑制重组ZIKV NS5聚合酶催化的RNA合成,IC50分别为7.3和5.2 μM。
  • 细胞实验证实sofosbuvir和DMB213抗ZIKV活性,EC50分别为8.3和4.6 μM。
  • DMB213不抑制重组HIV-1逆转录酶,对HIV-1整合酶链转移活性仅显示极弱抑制。
  • ZIKV RdRp motif B的S604T突变(对应HCV RdRp的S282T)导致对sofosbuvir三磷酸耐药,但不导致对DMB213耐药。
  • 酶学实验显示DMB213与天然核苷三磷酸(NTP)底物竞争。

临床怎么用

  • 重组ZIKV RdRp assay可作为筛选寨卡病毒抑制剂的工具,尤其适用于核苷类和非核苷金属离子螯合剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The viral RNA-dependent RNA polymerase (RdRp) enzymes of the Flaviviridae family are essential for viral replication and are logically important targets for development of antiviral therapeutic agents. Zika virus (ZIKV) is a rapidly re-emerging human pathogen for which no vaccine or antiviral agent is currently available. METHODS: To facilitate development of ZIKV RdRp inhibitors, we have established an RdRp assay using purified recombinant ZIKV NS5 polymerase. RESULTS: We have shown that both the hepatitis C virus (HCV) nucleoside inhibitor sofosbuvir triphosphate and a pyridoxine-derived non-nucleoside small-molecule inhibitor, DMB213, can act against ZIKV RdRp activity at IC 50 s of 7.3 and 5.2 μM, respectively, in RNA synthesis reactions catalysed by recombinant ZIKV NS5 polymerase. Cell-based assays confirmed the anti-ZIKV activity of sofosbuvir and DMB213 with 50% effective concentrations (EC 50 s) of 8.3 and 4.6 μM, respectively. Control studies showed that DMB213 did not inhibit recombinant HIV-1 reverse transcriptase and showed only very weak inhibition of HIV-1 integrase strand-transfer activity. The S604T substitution in motif B of the ZIKV RdRp, which corresponds to the S282T substitution in motif B of HCV RdRp, which confers resistance to nucleotide inhibitors, also conferred resistance to sofosbuvir triphosphate, but not to DMB213. Enzyme assays showed that DMB213 appears to be competitive with natural nucleoside triphosphate (NTP) substrates. CONCLUSIONS: Recombinant ZIKV RdRp assays can be useful tools for the screening of both nucleos(t)ide compounds and non-nucleotide metal ion-chelating agents that interfere with ZIKV replication.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Xu HT, Hassounah SA, Colby-Germinario SP, et al. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors. J Antimicrob Chemother. 2017. PMID: 28069884. doi:10.1093/jac/dkw514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。